General Innovative framework advances EEG-based emotion recognitionBy Healthcare Propulsion StaffNovember 5, 20260 Emotion recognition plays an important role in understanding human cognition and behavior, and has potential applications in brain-computer interfaces and…
General Topadur’s Phase 2a trial of TOP-N53 for systemic sclerosis-associated digital ulcers advances to next dose levelsBy Healthcare Propulsion StaffNovember 5, 20260 Topadur Pharma AG, a Swiss clinical-stage biopharmaceutical company, today announced that the Safety Review Committee of its Phase 2a trial…
General UCLA advances CRISPR gene-editing therapy for sickle cell diseaseBy Healthcare Propulsion StaffNovember 4, 20260 Findings A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood…
General $4 million NIH grant advances AI-guided heart failure treatmentBy Healthcare Propulsion StaffNovember 1, 20260 A $4 million grant from the National Institutes of Health is helping faculty researchers in the University of Virginia School…
